Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹9.45Admitted-Finance | ₹9.45 | L1 | Admitted-Finance |
| 2 | L2₹334.20Admitted-Finance | ₹334.20 | L2 | Admitted-Finance |
| 3 | L3₹409.50Admitted-Finance | ₹409.50 | L3 | Admitted-Finance |
| 4 | L4₹575.40Admitted-Finance | ₹575.40 | L4 | Admitted-Finance |
| 5 | L5₹10,380.30Admitted-Finance B 1 ANSAL CHAMBER 1 BHIKAJI CAMA PLACE DELHI NEW DELHI 110066 SOUTH WEST DELHI DELHI 110066 UDYAM DL 08 0039218 | NEW DELHI | DELHI | 110066 | ₹10,380.30 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | CONCEPT BIOMEDICAL L4 | SMPL Life Sciences Pvt. Ltd. L6 | Prakash Medicos L2 | M/S NEW WAVES L3 | SUPREME INTERNATIONAL PHARMACEUTICALS L5 | AKSHAT PHARMA PRIVATE LIMITED L8 | Medikon India Private Limited L7 | SAZ ENTERPRISES L1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Hematology | |||||||||||
| 1.01 | Plerixafor 24 mg Inj | 15 | VIAL | - | 6,000 ₹6,300 | - | - | 5,800 ₹6,090 | 8,690 ₹9,124.50 | 9,500 ₹9,975 | - |
| 2.01 | Cytosine Arabinoside (Cytarabine) (Preservative free) 100 mg Inj | 150 | VIAL | - | 46.2 ₹48.51 | - | - | - | - | 50 ₹52.50 | - |
| 3.01 | Cytosine Arabinoside 500mg Inj (Cytarabine) | 200 | VIAL | - | 162 ₹170.10 | - | - | - | - | 150 ₹157.50 | - |
| 4.01 | All-trans-retinoic acid 10 mg Cap | 2,250 | NO | - | 9.7 ₹10.18 | - | - | - | - | - | 9 ₹9.45 |
| 5.01 | Tab Sirolimus 1 mg | 1,550 | NO | - | - | - | - | - | - | - | - |
| 6.01 | Inj Thiotepa 15MG | 55 | VIAL | - | 4,860 ₹5,103 | - | - | 3,150 ₹3,307.50 | 6,050 ₹6,352.50 | 3,800 ₹3,990 | - |
| 7.01 | Methotrexate 15mg (Preservative Free) 3 ml Inj | 125 | VIAL | - | - | - | - | - | - | 40 ₹42 | - |
| 8.01 | Inj Bendamustine 100mg | 60 | VIAL | - | 529.2 ₹555.66 | - | - | 527 ₹553.35 | 780 ₹819 | - | - |
| 9.01 | FOSAPREPITANT 150 MG INJ | 50 | NO | 548 ₹575.40 | 448 ₹470.40 | 318.29 ₹334.20 | 390 ₹409.50 | 409 ₹429.45 | 560 ₹588 | 550 ₹577.50 | - |
Tender Value
₹3.4 L
EMD Value
₹17,206
Closing Date
6 Apr 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 1049 and 290,39/Haematology(Drugs)/IFA RE-152/2025-26 FOR AHRR
2026_ARMY_756459_1
2433/MS/EXP/D 1049 and 290,39/Haematology(Drugs)/IFA RE-152/2025-26
Open Tender
Medical Equipments/Waste
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹17,206
Yes
6 May 2026
16 Mar 2026
7 Apr 2026
16 Mar 2026
6 Apr 2026
16 Mar 2026
16 Mar 2026 - 6 Apr 2026
Dept of Hematology
Plerixafor 24 mg Inj
Cytosine Arabinoside (Cytarabine) (Preservative free) 100 mg Inj
Cytosine Arabinoside 500mg Inj (Cytarabine)
All-trans-retinoic acid 10 mg Cap
Tab Sirolimus 1 mg
Inj Thiotepa 15MG
Methotrexate 15mg (Preservative Free) 3 ml Inj
Inj Bendamustine 100mg
FOSAPREPITANT 150 MG INJ
Please Enable Macros to View BoQ information
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
BOQ_847335.xls
BOQ • 0.86 MB
RFP.pdf
Tender Documents • 1.32 MB
Download all tender documents and submit your bid